Journal Watch - Home Hemodialysis

« Back to Most Recent

  1. Tablo HD Machine Safe and Effective at Home and In-center

    Safety and efficacy human trials of the easy-to-use Tablo were conducted with 28 participants who received 4 treatments per week in-center and then at home for a total of 21 weeks. Home adherence (99%) was slightly better than in-center (96%), with average prescribed—and delivered—treatments of 3.4 hours, and an average weekly standard Kt/Vurea of 2.8 in both settings. Adverse events were not related to the Tablo, and alarm resolution time was 8 seconds in-center and 5 seconds at home.

    Read the abstract » | (added 11/16/2019)

    Tags: Tablo, Home Hemodialysis, Hemodialysis System

  2. A Patient on Home HD for 45 Years

    A 62-year old Mississippi woman, one of the first home HD patients of Dr. John D. Bower, is reported to have been on home HD for 45 years now, a record.

    Read the abstract » | (added 09/11/2019)

    Tags: Home Hemodialysis, Quality Of Life, Long Term Survival

  3. Home HD - Significantly Better Survival and Transplant Rate

    A Swedish matched cohort study compared the long-term survival of 152 home HD patients with those doing PD (n=456) or standard in-center HD (n=608). Median survival for home HD was significantly better (18.5 years) than PD (15.0) and in-center HD (11.9). Home HD patients were also significantly more likely to have received a transplant.

    Read the abstract » | (added 03/12/2019)

    Tags: Survival, Home Hemodialysis, Institutional Hemodialysis, Peritoneal Dialysis

  4. What Makes Home HD Patients Reach for On-Call Support?

    A 4-month prospective observational study analyzed the reasons why 58 home HD patients called the on-call nurse or technician. Most calls to nurses were made for clinical issues or machine set-up or alarm questions, some of which required a technician. Most of the technician calls were for machine malfunction, set-up and alarms, or water treatment. Read the abstract.

    Read the abstract » | (added 10/12/2018)

    Tags: Home Hemodialysis, Independent Hemodialysis, Nocturnal Hemodialysis, Short Daily Hemodialysis

  5. Blood Flow Rates and Clinically Meaningful Solute Removal

    A prospective study of 17 patients looked at BFRs of 300, 350, and 450 and Kt/V urea, beta-2 microglobulin, and phosphorus when low dialysate flow rates were used. While Kt/V did increase, the impact on B2M and phosphorus were minimal.

    Read the abstract » | (added 08/13/2018)

    Tags: Daily Hemodialysis, Home Hemodialysis, Kt/V, Blood Flow